Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × Depsipeptides × Clear all

Sponsor

Conditions

Lymphoma, T-Cell 2 Pancreatic Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large-Cell, Anaplastic 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Everolimus 16 Octreotide 6 pembrolizumab 5 lanreotide 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 gallium Ga 68 dotatate 4 cabozantinib 4 Nivolumab 4 Carboplatin 4 telotristat ethyl 3 lenvatinib 3 arginyllysine 3 Specimen Handling 3 Etoposide 3 Erlotinib Hydrochloride 3 Bevacizumab 3 surufatinib 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Temozolomide 2 Sorafenib 2 Phantoms, Imaging 2 Paclitaxel 2 Oxaliplatin 2 Ipilimumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡